Trump Administration Halts Federal Support for Gender-Affirming Care for Minors

New executive orders restrict medical treatments for transgender youth and redefine federal recognition of gender, prompting widespread policy changes and legal challenges.

President Donald Trump signed an executive order banning federal funding for gender-affirming care for individuals under 19, including puberty blockers, hormone therapy, and surgeries.
The order mandates that hospitals, medical schools, and other federally funded institutions cease providing such care or risk losing federal grants and funding.
Federal agencies have begun implementing the order, including changes to passport gender markers, prison housing policies, and the removal of transgender-inclusive resources from government websites.
LGBTQ+ advocacy groups, including Lambda Legal and the ACLU, have announced plans to challenge the policies, citing discrimination and potential harm to transgender youth.
Major medical organizations and experts continue to support gender-affirming care as safe and potentially life-saving, emphasizing its importance for the mental health and well-being of transgender individuals.